APA

Schnell R., Linnartz C., Katouzi A. A., Schön G., Bohlen H., Horn-Lohrens O., Parwaresch R. M., Lange H., Diehl V. & Lemke H. (19951204). Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen. : International journal of cancer.

Chicago

Schnell R, Linnartz C, Katouzi A A, Schön G, Bohlen H, Horn-Lohrens O, Parwaresch R M, Lange H, Diehl V and Lemke H. 19951204. Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen. : International journal of cancer.

Harvard

Schnell R., Linnartz C., Katouzi A. A., Schön G., Bohlen H., Horn-Lohrens O., Parwaresch R. M., Lange H., Diehl V. and Lemke H. (19951204). Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen. : International journal of cancer.

MLA

Schnell R, Linnartz C, Katouzi A A, Schön G, Bohlen H, Horn-Lohrens O, Parwaresch R M, Lange H, Diehl V and Lemke H. Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen. : International journal of cancer. 19951204.